Patients with ME, or chronic fatigue syndrome, are low in red blood cell magnesium and benefit from magnesium therapy.
That’s the conclusion of the first randomized placebo controlled, double blind trial (ie, one the medical community approves of) carried out at the University of Southampton medical school, which tested injected magnesium therapy against a placebo, both given to ME patients.
The study found that two thirds of the patients with ME had lower red cell magnesium concentrations than did healthy counterparts.
Of the 15 patients given intramuscular magnesium sulphate for six weeks, 12 reported improved energy levels, better emotional states and less pain compared to only 3 of the 17 controls.
Furthermore, the red blood cell magnesium of all the patients on magnesium returned to normal, compared to only one of the controls.